Evidence map›Paper›PMID 29914183›Full record

ArticleInternational journal of molecular sciences2018

Graviola (Annona muricata) Exerts Anti-Proliferative, Anti-Clonogenic and Pro-Apoptotic Effects in Human Non-Melanoma Skin Cancer UW-BCC1 and A431 Cells In Vitro: Involvement of Hedgehog Signaling.

Jean Christopher Chamcheu, Islam Rady, Roxane-Cherille N Chamcheu, Abu Bakar Siddique, Melissa B Bloch, Sergette Banang Mbeumi, Abiola S Babatunde, Mohammad B Uddin, Felicite K Noubissi, Peter W Jurutka and 4 more

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT04773769 (Pilot Phase 2 Study of Graviola), which is not on this map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT04773769 naunknown statusnot on this map

Pilot Phase 2 Study of Graviola (Guanabana) Leaves for The Treatment of Patients With Relapsed or Refractory Gastric Adenocarcinoma, Adenocarcinoma of Gastroesophageal Junction, Hepatocellular Carcinoma, Pancreatic Adenocarcinoma, Low Grade Lymphomas and Colorectal Adenocarcinoma

TypeinterventionalSponsorAuxilio Mutuo Cancer CenterRan2018 to 2023Enrolled54ConditionsGastric Adenocarcinoma, Adenocarcinoma of the Gastroesophageal Junction, Hepatocellular Carcinoma, Pancreatic AdenocarcinomaArmsTea Made of Graviola Leaves
3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Photoprotective Effect ofMolecules (Basel, Switzerland) · 2025
    Article
  3. Article
  4. Article
  5. Molecules (Basel, Switzerland) · 2023
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Anticancer Properties of Graviola (Oxidative medicine and cellular longevity · 2018
    Review
  11. Integrative cancer therapies
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 6 institutions in 1 country.

Jean Christopher ChamcheuDepartment of Basic Pharmaceutical Sciences, School of Pharmacy, College of Health and Pharmaceutic Sciences, University of Louisiana at Monroe, Monroe, 71209-0497 LA, USA. chamcheu@ulm.edu.ORCID 0000-0002-3927-5664
Islam RadyDepartment of Dermatology, School of Medicine and Public Health, University of Wisconsin, Madison, 53706 WI, USA. iabdelaal@wisc.edu.
Roxane-Cherille N ChamcheuDepartment of Dermatology, School of Medicine and Public Health, University of Wisconsin, Madison, 53706 WI, USA. roxanechamcheu@gmail.com.
Abu Bakar SiddiqueDepartment of Basic Pharmaceutical Sciences, School of Pharmacy, College of Health and Pharmaceutic Sciences, University of Louisiana at Monroe, Monroe, 71209-0497 LA, USA. siddiqab@warhawks.ulm.edu.ORCID 0000-0001-5424-9475
Melissa B BlochDepartment of Basic Pharmaceutical Sciences, School of Pharmacy, College of Health and Pharmaceutic Sciences, University of Louisiana at Monroe, Monroe, 71209-0497 LA, USA. blochmb@warhawks.ulm.edu.
Sergette Banang MbeumiDivision for Research and Innovation, POHOFI Inc., P.O. Box 44067, Madison, 53744 WI, USA. sbmbeumi@pohofi.org.
Abiola S BabatundeDepartment of Basic Pharmaceutical Sciences, School of Pharmacy, College of Health and Pharmaceutic Sciences, University of Louisiana at Monroe, Monroe, 71209-0497 LA, USA. asbabatunde@unilorin.edu.ng.ORCID 0000-0002-8092-6844
Mohammad B UddinDepartment of Basic Pharmaceutical Sciences, School of Pharmacy, College of Health and Pharmaceutic Sciences, University of Louisiana at Monroe, Monroe, 71209-0497 LA, USA. burhan1129@gmail.com.
Felicite K NoubissiDepartment of Biology, Jackson State University, Jackson, 39217 MS, USA. felicite.noubissi_kamdem@jsums.edu.ORCID 0000-0002-3192-5132
Peter W JurutkaSchool of Mathematical and Natural Sciences, Arizona State University, Phoenix, 85306 AZ, USA. peter.jurutka@asu.edu.ORCID 0000-0002-4950-9161
Yong-Yu LiuDepartment of Basic Pharmaceutical Sciences, School of Pharmacy, College of Health and Pharmaceutic Sciences, University of Louisiana at Monroe, Monroe, 71209-0497 LA, USA. yliu@ulm.edu.
Vladimir S SpiegelmanDivision of Pediatric Hematology/Oncology, Department of Pediatrics, Pennsylvania State University, College of Medicine, Hershey, 17033 PA, USA. vspiegelman@pennstatehealth.psu.edu.
G Kerr WhitfieldDepartment of Basic Medical Sciences, University of Arizona College of Medicine-Phoenix, Phoenix, 85004 AZ, USA. gkw@email.arizona.edu.
Khalid A El SayedDepartment of Basic Pharmaceutical Sciences, School of Pharmacy, College of Health and Pharmaceutic Sciences, University of Louisiana at Monroe, Monroe, 71209-0497 LA, USA. elsayed@ulm.edu.ORCID 0000-0002-1456-4064
University of Louisiana at Monroe · USUniversity of Wisconsin–Madison · USArizona State University · USJackson State University · USPennsylvania State University · USUniversity of Arizona · US

Funding

RNA-binding protein CRD-BP in melanocyte biologyR01AR063361 · NIAMS · UNIVERSITY OF WISCONSIN-MADISON · PI SPIEGELMAN, VLADIMIR S. · 2013 to 2017
$1.6M
CRD-BP-mediated regulation of Wnt signaling in intestinal tumorigenesisR21CA191550 · NCI · UNIVERSITY OF WISCONSIN-MADISON · PI SPIEGELMAN, VLADIMIR S. · 2015 to 2016
$364k
NCI NIH HHS R21 CA191550NIAMS NIH HHS R01 AR063361
6 · The paper itself

Abstract

Non-melanoma skin cancers (NMSCs) are the leading cause of skin cancer-related morbidity and mortality. Effective strategies are needed to control NMSC occurrence and progression. Non-toxic, plant-derived extracts have been shown to exert multiple anti-cancer effects. Graviola (

Indexed as

AnnonaAntineoplastic AgentsApoptosisCell CycleCell Line, TumorCell MovementCell ProliferationHedgehog ProteinsHumansPlant ExtractsSignal TransductionSkin NeoplasmsTumor Stem Cell AssayAntineoplastic AgentsHedgehog ProteinsPlant ExtractsAnnona muricataapoptosisbasal cell carcinomacutaneous squamous cell carcinomagraviolaHedgehog signaling pathwaynatural products chemistrynon-melanoma skin cancer

Identifiers

PMID29914183
PMCPMC6032424
OpenAlexW2806302401

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.